Cytodyn Inc (CYDY)

[Rockleo]

Saltz..Factually there is NO need to give Leronlimab to MILD Corona patients.. In my estimation from my patient’s..About 85%. New2 above 4.. would be a STAND OUT.. These Moderate patient’s account for the ENTIRE 0.8% Mortality in the US.. Leronlimab would be IDEAL for this 15%..Stop hospital admissions..Stop intubations..ICU admissions..AND Long hauler Development..!!!

WHY have we waited 5 weeks to hear the FDA refused to entertain Leronlimab for Mild to Moderate..?? We should have started and perhaps ended that Study in 8 week for Moderate News2 ..Patients above a score of 4....!!! Long Haulers should NOT be a part of this Phase 3 MODERATE Trial..!!!

Long Haulers should be a different animal altogether..People out 6 weeks from Covid detection..WITH persistent symptoms..The fact that 30% of OUR Mild to Moderate patient’s had ZERO News2 Scores..Upsets me..AS WE UNDERMINED Leronlimab..!!!

It’s like trying a Diabetic Drug on a patient with NO diabetes..and concluding ..It’s no different than a placebo..??

Leronlimab IS the real deal ..It will save OUR NATION..

Let’s GO.. !!!